FiercePharma

In addressing inspection shortfall, FDA says it's gaining more inspectors than it's losing

In its effort to play catch up after thousands of factory inspections were delayed during the coronavirus pandemic, the FDA is still lagging woefully behind and is unable to approach its pre-COVID ...
MarketWatch

2 Day Virtual Drug and Biotech Products FDA Regulatory Compliance Training Course: Practical Applications of the Graded Approach in Manufacturing, Testing, and Quality Control ...

The "FDA Regulatory Compliance for Drug and Biotech Products (Nov 12th - Nov 13th, 2025)" training has been added to ResearchAndMarkets.com's offering. Regulatory Compliance is the level of activity ...
Becker's Hospital Review

Drug inspectors warn of slower checks following FDA layoffs

Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...
Fast Company

FDA drug-plant inspections still haven’t recovered from the pandemic, AP reports

As COVID-19 swept across the globe in early 2020, the Food and Drug Administration (FDA) pulled most of its safety inspectors from the field, creating a massive backlog of uninspected pharmaceutical ...
Northwest Arkansas Democrat Gazette

FDA’s inspections still lag pre-pandemic period

WASHINGTON -- Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the covid-19 pandemic upended factory ...

Rx Inspector: ProPublica’s New Tool Provides Drug Info the FDA Won’t

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...